Literature DB >> 10497170

Mutations in the primer grip region of HIV reverse transcriptase can increase replication fidelity.

M Wisniewski1, C Palaniappan, Z Fu, S F Le Grice, P Fay, R A Bambara.   

Abstract

Mutations in the primer grip region of human immunodeficiency virus reverse transcriptase (HIV-RT) affect its replication fidelity. The primer grip region (residues 227-235) correctly positions the 3'-ends of primers. Point mutations were created by alanine substitution at positions 224-235. Error frequencies were measured by extension of a dG:dA primer-template mismatch. Mutants E224A, P225A, P226A, L228A, and E233A were approximately equal to the wild type in their ability to extend the mismatch. Mutants F227A, W229A, M230A, G231A, and Y232A extended 40, 66, 54, 72, and 76% less efficiently past a dG:dA mismatch compared with the wild type. We also examined the misinsertion rates of dG, dC, or dA across from a DNA template dA using RT mutants F227A and W229A. Mutant W229A exhibited high fidelity and did not produce a dG:dA or dC:dA mismatch. Interestingly, mutant F227A displayed high fidelity for dG:dA and dC:dA mismatches but low fidelity for dA:dA misinsertions. This indicates that F227A discriminates against particular base substitutions. However, a primer extension assay with three dNTPs showed that F227A generally displays higher fidelity than the wild type RT. Clearly, primer grip mutations can improve or worsen either the overall or base-specific fidelity of HIV-RT. We hypothesize that wild type RT has evolved to a fidelity that allows genetic variation without compromising yield of viable viruses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497170     DOI: 10.1074/jbc.274.40.28175

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine.

Authors:  Matthew M Schuckmann; Bruno Marchand; Atsuko Hachiya; Eiichi N Kodama; Karen A Kirby; Kamalendra Singh; Stefan G Sarafianos
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

Review 2.  Adaptive value of high mutation rates of RNA viruses: separating causes from consequences.

Authors:  Santiago F Elena; Rafael Sanjuán
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  The cost of replication fidelity in an RNA virus.

Authors:  Victoria Furió; Andrés Moya; Rafael Sanjuán
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

Review 4.  Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise.

Authors:  Stuart F J Le Grice
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

5.  The cost of replication fidelity in human immunodeficiency virus type 1.

Authors:  Victoria Furió; Andrés Moya; Rafael Sanjuán
Journal:  Proc Biol Sci       Date:  2007-01-22       Impact factor: 5.349

6.  A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Kelly Soderberg; Lynn Denekamp; Sarah Nikiforow; Karen Sautter; Ronald C Desrosiers; Louis Alexander
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  A mutation in the primer grip region of HIV-1 reverse transcriptase that confers reduced fidelity of DNA synthesis.

Authors:  M Gutiérrez-Rivas; L Menéndez-Arias
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

8.  Structure-based evaluation of C5 derivatives in the catechol diether series targeting HIV-1 reverse transcriptase.

Authors:  Kathleen M Frey; William T Gray; Krasimir A Spasov; Mariela Bollini; Ricardo Gallardo-Macias; William L Jorgensen; Karen S Anderson
Journal:  Chem Biol Drug Des       Date:  2014-03-14       Impact factor: 2.817

9.  Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase.

Authors:  Kamalendra Singh; Bruno Marchand; Karen A Kirby; Eleftherios Michailidis; Stefan G Sarafianos
Journal:  Viruses       Date:  2010-02-11       Impact factor: 5.048

10.  Novel Mutations L228I and Y232H Cause Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Combinational Pattern.

Authors:  Xiao-Min Zhang; Qiwei Zhang; Hao Wu; Terrence Chi-Kong Lau; Xuan Liu; Hin Chu; Ke Zhang; Jie Zhou; Zhi-Wei Chen; Dong-Yan Jin; Bo-Jian Zheng
Journal:  AIDS Res Hum Retroviruses       Date:  2016-05-09       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.